BioCentury
ARTICLE | Clinical News

Genvascor: Phase I/II trials update

October 16, 2000 7:00 AM UTC

Collateral Therapeutics Inc. (CLTX), San Diego, Calif. Product: Genvascor Business: Gene/Cell therapy, Cardiovascular Therapeutic category: Gene therapy, Angiogenesis Target: Endothelial cells Descri...